Unknown

Dataset Information

0

Therapeutic effect of ?-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK.

ABSTRACT: Here, we have investigated the role of the Notch pathway in the generation and maintenance of Kras(G12V)-driven non-small cell lung carcinomas (NSCLCs). We demonstrate by genetic means that ?-secretase and RBPJ are essential for the formation of NSCLCs. Of importance, pharmacologic treatment of mice carrying autochthonous NSCLCs with a ?-secretase inhibitor (GSI) blocks cancer growth. Treated carcinomas present reduced HES1 levels and reduced phosphorylated ERK without changes in phosphorylated MEK. Mechanistically, we show that HES1 directly binds to and represses the promoter of DUSP1, encoding a dual phosphatase that is active against phospho-ERK. Accordingly, GSI treatment upregulates DUSP1 and decreases phospho-ERK. These data provide proof of the in vivo therapeutic potential of GSIs in primary NSCLCs.

SUBMITTER: Maraver A 

PROVIDER: S-EPMC3813920 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Here, we have investigated the role of the Notch pathway in the generation and maintenance of Kras(G12V)-driven non-small cell lung carcinomas (NSCLCs). We demonstrate by genetic means that γ-secretase and RBPJ are essential for the formation of NSCLCs. Of importance, pharmacologic treatment of mice carrying autochthonous NSCLCs with a γ-secretase inhibitor (GSI) blocks cancer growth. Treated carcinomas present reduced HES1 levels and reduced phosphorylated ERK without changes in phosphorylated  ...[more]

Similar Datasets

Unknown Therapeutic effect of ?-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma through derepression of DUSP1 phosphatase and inhibition of ERK
| S-ECPF-GEOD-38054 | biostudies-other
Transcriptomics Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma through derepression of DUSP1 phosphatase and inhibition of ERK
2012-12-01 | E-GEOD-38054 | biostudies-arrayexpress
Transcriptomics Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma through derepression of DUSP1 phosphatase and inhibition of ERK
2012-12-01 | GSE38054 | GEO
Unknown ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells.
| S-EPMC5844726 | biostudies-literature
Unknown ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer.
| S-EPMC3681842 | biostudies-literature
Unknown DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small cell lung cancer
| S-ECPF-GEOD-19592 | biostudies-other
Unknown Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
| S-EPMC6318062 | biostudies-literature
Unknown Synergistic Effects of NOTCH/?-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells.
| S-EPMC6234899 | biostudies-literature
Unknown The Inhibition of Wnt Restrain KRASG12V-Driven Metastasis in Non-Small-Cell Lung Cancer.
| S-EPMC7226522 | biostudies-literature
Unknown Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC).
| S-EPMC4630516 | biostudies-literature